comprehensive -WSS

comprehensive

author：fashion 2025-09-27 13:02:24 - browse：978

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Congressmen charge Covid hearing ‘could have been an email’

WSS

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Living organ donors deserve priority status for transplants

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Mom launches Girl Scout troop for LGBTQ youth in Texas

FDA approves first new drug developed for postpartum depression

knowledge

comprehensive

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Eli Lilly’s Mounjaro succeeds in second weight

Duchenne breakthrough therapy leaves behind pioneering families

Sea level rise could wash away turtle breeding grounds around the world, researchers say

In Memoriam: Notable people who died in 2023

Biden administration opens offers in Medicare drug price negotiations

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Bispecific antibodies are next new thing in cancer immunotherapy

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Covid misinformation case heads to Supreme Court

leisure time

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Covid misinformation case heads to Supreme Court

Xenotransplantation trials will require adjusting expectations, experts say

Mom launches Girl Scout troop for LGBTQ youth in Texas

Bispecific antibodies are next new thing in cancer immunotherapy

Inside the rise of 'mukbang' eating videos

entertainment

hotspot

focus

focus